Finance

Beta
Lists
ALXO:NASDAQ
ALX Oncology Holdings Inc
$1.54
-1.28%
(-0.020) 1D
$1.54
-0.06% (-0.00090)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALXO...
Open
$1.58
High
$1.64
Low
$1.52
Mkt. cap
207.23M
Avg. vol.
1.01M
Volume
858.47K
52-wk high
$2.66
52-wk low
$0.41
EPS
-$1.49
Beta
0.44
Shares outstanding
134.56M
No. of employees
43
Open
$1.58
High
$1.64
Low
$1.52
Mkt. cap
207.23M
Avg. vol.
1.01M
Volume
858.47K
52-wk high
$2.66
52-wk low
$0.41
EPS
-$1.49
Beta
0.44
Shares outstanding
134.56M
No. of employees
43
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to ALXO in the past 3 months
Strong Buy
Buy
4
Hold
1
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ALXO in the last 3 months.
Highest
Current $1.54
$6.00 (+289.61%)
Average
$4.75 (+208.44%)
Lowest
$4.00 (+159.74%)
News stories
From sources across the web
About ALX Oncology Holdings Inc
CEO-
Employees43
Founded2015
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitealxoncology.com
Last report
May 8, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.17 / -$0.16
-7.91%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
18.02M
17.44M
17.64M
13.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.45M
5.09M
5.38M
5.36M
Operating expense
23.47M
22.53M
23.02M
18.97M
Total operating expenses
23.47M
22.53M
23.02M
18.97M
Operating income
-23.47M
-22.53M
-23.02M
-18.97M
Other non operating income
-
-
-
188.00K
EBT including unusual items
-25.95M
-22.14M
-22.85M
-17.93M
EBT excluding unusual items
-22.77M
-22.14M
-22.85M
-17.93M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-25.95M
-22.14M
-22.85M
-17.93M
Net profit margin
-
-
-
-
Earnings per share
-0.44
-
-0.37
-0.15
Interest and investment income
1.11M
802.00K
573.00K
1.18M
Interest expense
-405.00K
-408.00K
-383.00K
-331.00K
Net interest expenses
701.00K
394.00K
190.00K
851.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-23.28M
-22.38M
-22.87M
-18.82M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer